Parkman Healthcare Partners’s Procept Biorobotics PRCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-67,252	Closed	-$1.91M	–	103
2023 Q1	$1.91M	Sell	67,252 -45,066	-40%	-$1.28M	0.42%	58
2022 Q4	$4.67M	Buy	112,318 +11,117	+11%	+$462K	1.24%	30
2022 Q3	$4.2M	Buy	101,201 +6,701	+7%	+$278K	1.19%	27
2022 Q2	$3.09M	Buy	+94,500	New	+$3.09M	1.14%	29